The financial playbook for medical spa owners.

53% of med spas haven't adopted AI for patient communication. Six questions to ask before signing with any AI receptionist vendor, including the HIPAA trap most owners miss.

Botox, Dysport, and Daxxify use incompatible unit systems. Calculate real cost per treatment from your vendor invoices and compare brands correctly.

52% of practices invest under $2,500/month on marketing. The benchmark is 5% of gross revenue. How to size your budget, allocate across channels, and measure whether it is working.

GLP-1 programs contribute 15% of monthly revenue at practices offering them. How to calculate your own contribution rate and what separates a 10% program from a 25% one.

Most med spas run 10 to 15 points below their EBITDA target because injectable COGS, deferred revenue, and device leases are never correctly mapped. Here is the audit and the fix.

At $50K/month with 12 competitors nearby, the revenue is not the problem. Saturation does to med spa margins and which financial levers move first.

Year one is a paid research period. Real CPA benchmarks by channel, a 90-day launch framework, and the budget math to reach 10 new patients a week by month six.

Most practices measure CPA and stop there. Six outreach moves that hold up under lifetime value math, with channel benchmarks and a full consult-to-close framework.

Four of five manufacturer programs deliver a price discount, not a check. Galderma is the exception, and most practices misbook the rebate they do get.

AMSPA says injectors aren't good 1099 candidates. See the $242K break-even, commission structures for both models, cross-sell protocol, and the culture case for W-2.

Premiums run $900–$14,000/year based on 28 real operator quotes. Six underwriting factors explain the spread, and most are knowable before your next renewal.

Labor above 42% of revenue is the warning line. Above 50%, the practice loses money on growth. How to calculate it and what to do when the number starts drifting.

Recording package sales as revenue on collection overstates monthly profit by thousands. Most med spa books never use deferred revenue. Here is the correct setup.

Your real injectable margin is 60–70% after vendor COGS, not the 80%+ QuickBooks shows. Step-by-step calculation with a worked Botox example and per-treatment breakdown.

Allergan invoices sit in email. QBO shows 80 to 90 percent injectable margin. The real number is 60 to 70. Six-step reconciliation with a worked Botox example.

AbbVie's Botox revenue fell 4.1% in 2025 while Galderma's neuromodulator line grew 14.3%. What that split means for your injectable COGS and how to reconcile vendor invoices against POS revenue.

The average med spa runs at 47% staff utilization. Top earners run at 78%. The revenue gap between those two numbers at a typical practice is over $2 million per year.

Membership sales grew 24% in 2024. Most med spas book it as revenue when collected. That is wrong. The correct treatment uses deferred revenue, and this post shows the journal entries.

A profitable med spa can still miss payroll. The P&L records revenue when a service is delivered; cash arrives days or weeks later. Here is where the timing gap lives and five policy changes that close it.

A well-run single-location medical spa acquires new patients at $150 to $300 all-in, based on AMSPA 2024 data. Most owners can quote their revenue. Almost none can tell you what it cost to acquire the patients who generated it.

Vagaro and Mindbody record revenue when money hits the register. QuickBooks records it when the service is delivered. For a practice with packages, memberships, and gift cards, those are rarely the same month.

The BLS puts nurse practitioner mean wages at $132,050 annually and licensed estheticians at $19.98 per hour. Here is how those figures translate to a med spa P&L and where most practices overpay.

Injectables at 55-65%, laser at 15-20%, memberships at 5-10%. When the mix drifts, margin follows. Here are the benchmarks and how to measure yours.

Zenoti data from 30,000+ businesses puts average med spa revenue at $1,035,229. Top earners reach $3,219,354. The P&L structure at each tier is completely different.

Juvederm revenue fell 15.3% in 2025 while Galderma's filler segment grew 8%. If your practice is switching product lines, your COGS accounting needs to change at the same time.

The 2026 Section 179 limit is $2,560,000 per Rev. Proc. 2025-32, and bonus depreciation is back to 100% under the One Big Beautiful Bill Act. Here is how to apply both to med spa equipment purchases.

Medspas have the highest no-show rate of any beauty category at 5%, plus a 16% cancellation rate. At average ticket sizes, that adds up to over $17,000 in monthly revenue leakage for a typical practice.

The medical spa market is projected to reach $26.2 billion by 2030, but 81% of practices are single-location owner-operators with no fractional CFO and no weekly P&L. That is the gap Spa Ledger fills.

Average revenue $1.04M to $1.39M. Profit margins at 38%. Labor target 35–42%. Injectable COGS 30–40%. All the benchmarks a med spa owner and CFO need, sourced and cited.

QuickBooks, Xero, or Wave for your med spa? How each handles injectable COGS, service-line P&L, and the gaps every option leaves open.

The default QuickBooks chart of accounts has no line for injectable product expense, no device lease account, and no structure for MSO/PC separation. Here is the correct setup.

Break-even formula, Section 179 treatment, and utilization benchmarks for med spa laser and body contouring devices. The calculation most owners have never run.

Target 27–38% EBITDA at $1–1.5M revenue. Most practices run 10–15 points below that. The four line items that explain the gap: labor, injectable COGS, device leases, owner comp.

A bookkeeper closes the books. A fractional CFO tracks injectable COGS weekly, flags labor drift, and tells you whether your device lease is generating a return. Most med spas have neither.

An MSO/PC structure requires two separate QuickBooks files and an intercompany management fee. Running both entities through one P&L is the most common compliance gap in med spa finance.

Buyers underwrite on three years of normalized EBITDA. Deferred revenue misstatements, commingled MSO/PC books, and above-market owner comp are the three items most likely to reduce your valuation.

Five metrics every week: revenue by service line, labor percentage against 35–42%, injectable COGS reconciled against vendor invoices, device utilization, and rebooking rate vs. the 40% benchmark.

An NP at $132,050 base needs to generate roughly $434,000 in annual revenue at a 40% COGS load to clear a 25% contribution margin. Most med spas have never run this number by provider.

Zenoti and Boulevard record transactions. They do not allocate COGS, recognize deferred revenue, or produce a balance sheet. Five things your POS skips and what QuickBooks needs to handle instead.

Base salary plus commission above a threshold outperforms straight commission at 3 of 4 revenue tiers. The net-of-consumables formula, the compliance risk, and the revenue level where each model makes sense.

Most med spas expense Allergan and Galderma invoices to a generic supplies account. That hides your real injectable margin. Here is the 6-step fix and the chart of accounts structure that makes it permanent.

Recording package sales as revenue at collection overstates monthly profit by $10,000–$50,000. Here is the correct deferred revenue fix and why most med spa P&Ls are wrong before this entry gets made.

Right company type, class tracking by service line, injectable COGS accounts by drug class, device depreciation, and the 8 configuration mistakes most owners make when they set up QuickBooks themselves.